Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NXTC

NextCure (NXTC)

NextCure Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NXTC
DateTimeSourceHeadlineSymbolCompany
07/03/202508:05GlobeNewswire Inc.NextCure Provides Business Update and Reports Full Year 2024 Financial ResultsNASDAQ:NXTCNextCure Inc
15/02/202505:40Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NXTCNextCure Inc
07/02/202508:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NXTCNextCure Inc
04/02/202510:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXTCNextCure Inc
04/02/202510:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NXTCNextCure Inc
04/02/202508:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
11/01/202500:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
11/01/202500:05GlobeNewswire Inc.NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple CancersNASDAQ:NXTCNextCure Inc
11/12/202400:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
11/12/202400:05GlobeNewswire Inc.NextCure Announces Acceptance of IND Application for LNCB74NASDAQ:NXTCNextCure Inc
05/12/202423:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
26/11/202423:00GlobeNewswire Inc.NextCure to Participate in the 36th Annual Piper Sandler Healthcare ConferenceNASDAQ:NXTCNextCure Inc
20/11/202400:05GlobeNewswire Inc.Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis ImperfectaNASDAQ:NXTCNextCure Inc
15/11/202410:59Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NXTCNextCure Inc
08/11/202408:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXTCNextCure Inc
08/11/202408:05GlobeNewswire Inc.NextCure Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:NXTCNextCure Inc
06/11/202408:05GlobeNewswire Inc.NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual MeetingNASDAQ:NXTCNextCure Inc
04/10/202423:05GlobeNewswire Inc.NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual MeetingNASDAQ:NXTCNextCure Inc
16/09/202422:05GlobeNewswire Inc.NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024NASDAQ:NXTCNextCure Inc
02/08/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXTCNextCure Inc
02/08/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
02/08/202406:05GlobeNewswire Inc.NextCure Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:NXTCNextCure Inc
21/06/202406:10GlobeNewswire Inc.NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:NXTCNextCure Inc
19/06/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXTCNextCure Inc
31/05/202406:05GlobeNewswire Inc.NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024NASDAQ:NXTCNextCure Inc
03/05/202406:05GlobeNewswire Inc.NextCure Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:NXTCNextCure Inc
25/04/202406:05GlobeNewswire Inc.NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024NASDAQ:NXTCNextCure Inc
08/04/202421:00GlobeNewswire Inc.NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024NASDAQ:NXTCNextCure Inc
04/04/202422:05GlobeNewswire Inc.NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory BoardNASDAQ:NXTCNextCure Inc
02/04/202422:00GlobeNewswire Inc.NextCure to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:NXTCNextCure Inc
 Showing the most relevant articles for your search:NASDAQ:NXTC